Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
Post
-
-
Nottingham University and Aboca collaborate on MRI feasibility study
The University of Nottingham in the UK has announced a collaboration with Italy’s Aboca and specialists from the University’s Sir …
-
IGC Pharma adds New York site for Alzheimer’s disease trial
IGC Pharma has expanded its CALMA Phase II clinical trial by adding Integrative Clinical Trials, based in Brooklyn, New York, …
-
Daiichi Sankyo and AstraZeneca’s Enhertu gains NMPA approval for HER2 GEJ
Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) has received approval from China’s National Medical Products Administration (NMPA) for adults with …
-
SonoMotion gains FDA clearance for Break Wave device to treat kidney stones
SonoMotion has received the US Food and Drug Administration (FDA) 510(k) clearance for its Break Wave non-invasive kidney stone treatment …
-
Worldwide Clinical Trials to acquire Catalyst
Worldwide Clinical Trials has entered a definitive agreement to acquire oncology contract research organisation (CRO) Catalyst Clinical Research. The transaction will …
-
Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
-
Opna Bio’s OPN-2853 secures FDA’s orphan drug status for myelofibrosis
Opna Bio has received the US Food and Drug Administration’s (FDA) orphan drug designation for OPN-2853 (zavabresib), a bromodomain and …
-
Al Naghi to distribute QT Imaging Breast Acoustic scanners in UAE
QT Imaging has signed an exclusive distribution agreement with Al Naghi Medical (NMC) for its QTI Breast Acoustic CT [computed …
-
Lipocine completes Phase III enrolment for LPCN 1154 in PPD
Lipocine has announced the completion of enrolment and participant dosing in its Phase III clinical trial investigating LPCN 1154, an …
-
Novo Nordisk and Aspect Biosystems advance partnership for diabetes therapies
Novo Nordisk and Aspect Biosystems have commenced a new phase in their ongoing partnership focused on curative cellular medicines to …
-
Passwordless authentication at top of healthcare IT leaders’ priorities, report shows
A new survey by security firm Imprivata has found that a majority of IT leaders in healthcare view ‘passwordless’ authentication …
-
Hospital cybersecurity: the threat in every HCP’s pocket
The use of mobile devices in hospitals to streamline workflows and improve patient care has become commonplace. For cyber-attackers, this …
-
Guardant and MSD collaborate on companion diagnostics development
Guardant Health has entered a multi-year strategic partnership agreement with Merck & Co (MSD) for the development of companion diagnostics. The …
-
Nxera reports positive outcomes for daridorexant Phase III insomnia study
Nxera Pharma has announced positive top-line results from its Phase III study of daridorexant 50mg, aimed at treating insomnia in …
-
iRegene receives FDA RMAT designation for NouvNeu001 to treat Parkinson’s
iRegene Therapeutics has received regenerative medicine advanced therapy (RMAT) designation from the US Food and Drug Administration (FDA) for its …
-
Zylox-Tonbridge to acquire German medical technology company Optimed
Zylox-Tonbridge, a Hong Kong-listed company specialising in neurovascular and peripheral vascular interventional products, has agreed to acquire German medical technology …
